Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial

Affiliations

• ¹ University of Liverpool and Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
• ² University of Liverpool, Liverpool, UK.
• ³ University of Birmingham, Birmingham, UK.
• ⁴ Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
• ⁵ The Royal Bournemouth Hospital, Bournemouth, UK.
• ⁶ The Christie NHS Foundation Trust, Manchester, UK.
• ⁷ Churchill Hospital, Oxford, UK.
• ⁸ Southampton General Hospital, Southampton, UK.
• ⁹ Royal Marsden NHS Foundation Trust, Sutton, UK.
• ¹⁰ University Hospital of Wales, Cardiff, UK.
• ¹¹ Leicester Royal Infirmary, Leicester, UK.
• ¹² City Hospitals Sunderland NHS Trust, Sunderland, UK.
• ¹³ Nottingham University Hospitals NHS Trust, Nottingham, UK.
• ¹⁴ University of Leeds, Leeds, UK.